F-14/15, Orbit Mall, Civil Lines, Jaipur-302006
support@thetaxheaven.com
F-14/15, Orbit Mall, Civil Lines, Jaipur-302006 support@thetaxheaven.comFischer Medical Ventures Ltd is a growing player in the healthcare and medical technology sector. Known for its innovative approach and expanding product portfolio, the company has gained attention in the Indian stock market. With a strong promoter holding and increasing institutional interest, investors are closely tracking Fischer Medical’s performance.
In this article, we will explore Fischer Medical Ventures’ share price targets from 2025 to 2030, along with a look at its business fundamentals, current market performance, and investment outlook.
| Detail | Value |
|---|---|
| Current Price | ₹1,168.00 |
| Previous Close | ₹1,160.90 |
| Day’s High | ₹1,194.40 |
| Day’s Low | ₹1,104.10 |
| 52-Week High | ₹1,194.40 |
| 52-Week Low | ₹770.10 |
| Market Capitalization | ₹7,134 Cr |
| Beta (Volatility) | 1.07 |
| VWAP | ₹1,141.47 |
| Upper Circuit Limit | ₹1,393.00 |
| Lower Circuit Limit | ₹928.80 |
| All-Time High | ₹1,194.40 |
| All-Time Low | ₹770.10 |
| 20D Avg Volume | 52,462 |
| 20D Avg Delivery (%) | 34.84% |
| Book Value Per Share | ₹14.32 |
| Face Value | ₹10 |
Fischer Medical Ventures Ltd is engaged in the healthcare and medical devices segment. The company primarily focuses on providing advanced medical imaging and diagnostic solutions, making it an important player in India’s growing healthcare sector. With rising demand for healthcare services, advanced medical infrastructure, and technological innovation, Fischer Medical is well-positioned for long-term growth.
Strong market capitalization of ₹7,134 Cr, reflecting growth potential.
Healthy promoter holding of 61.80%, showing management’s confidence.
Significant retail participation at 32.65%, indicating rising popularity among investors.
Consistent growth in stock price, recently hitting an all-time high of ₹1,194.40.
Positioned in the fast-growing medical technology sector, which benefits from healthcare expansion in India.
| Investor Type | Holding (%) |
|---|---|
| Promoters | 61.80% |
| Retail & Others | 32.65% |
| Foreign Institutions | 5.55% |
A strong promoter base ensures stability, while growing foreign institutional interest indicates confidence in the company’s global potential.
| Year | Minimum Target (₹) | Maximum Target (₹) |
|---|---|---|
| 2025 | 1,150 | 1,250 |
| 2026 | 1,280 | 1,400 |
| 2027 | 1,420 | 1,600 |
| 2028 | 1,580 | 1,750 |
| 2029 | 1,720 | 1,950 |
| 2030 | 1,900 | 2,150 |
The stock is trading close to its all-time high, reflecting strong investor confidence. With rising demand in the healthcare sector, the stock is expected to remain steady in 2025.
Investment Advice: Good for long-term holding; investors may accumulate during dips.
In 2026, Fischer Medical may benefit from technological upgrades and increasing market penetration in India.
Investment Advice: Hold for medium to long term; monitor quarterly growth.
By 2027, Fischer Medical could see significant growth due to higher adoption of medical imaging technologies.
Investment Advice: Reinvest profits for compounding growth.
Expansion of healthcare infrastructure and greater government spending in the sector can push the stock higher.
Investment Advice: Continue long-term investments; potential CAGR is attractive.
With stronger global presence and growing demand, Fischer Medical may continue upward momentum.
Investment Advice: Suitable for medium- to long-term portfolios.
By 2030, Fischer Medical Ventures could emerge as one of the top healthcare technology companies in India, making it a strong long-term wealth creator.
Investment Advice: Excellent for long-term investors seeking growth in the healthcare sector.
Yes, Fischer Medical Ventures Ltd is a promising long-term investment due to:
Strong promoter holding of 61.80%.
Growing foreign institutional interest.
Rising demand for advanced healthcare solutions.
Consistent growth and sectoral strength.
High volatility due to sector dynamics.
Dependency on government healthcare policies.
Competition from other medical technology firms.
Fischer Medical Ventures Ltd is positioned well in the healthcare and medical technology industry. With a strong promoter backing, institutional participation, and robust market performance, the company shows potential to reach ₹2,150 by 2030.
For investors seeking long-term exposure in healthcare and technology-driven sectors, Fischer Medical Ventures can be a valuable addition to their portfolio.
1. What is the share price target of Fischer Medical Ventures in 2025?
The target for 2025 is between ₹1,150 – ₹1,250.
2. What is the expected share price of Fischer Medical Ventures in 2030?
By 2030, the stock could reach ₹1,900 – ₹2,150.
3. Is Fischer Medical Ventures a good long-term investment?
Yes, due to its strong promoter holding and growing presence in healthcare technology.
4. What is the 52-week high and low of Fischer Medical Ventures?
The 52-week high is ₹1,194.40, and the 52-week low is ₹770.10.
5. What is the market capitalization of Fischer Medical Ventures Ltd?
As of 2025, the market cap is around ₹7,134 Cr.
6. What is the all-time high and low of Fischer Medical Ventures stock?
All-time high is ₹1,194.40, and all-time low is ₹770.10.
7. Who are the major shareholders of Fischer Medical Ventures?
Promoters hold 61.80%, retail investors 32.65%, and FIIs 5.55%.
8. Does Fischer Medical Ventures pay dividends?
The dividend yield is currently negligible, as the company focuses on growth.
9. Should I buy Fischer Medical Ventures stock now?
Yes, investors with a long-term perspective can consider buying at current levels.
10. What is the book value per share of Fischer Medical Ventures?
The book value per share is ₹14.32.
Disclaimer: This article is for educational purposes only. Please consult a SEBI-registered financial advisor before making investment decisions.
Register & Login